Efficacy and Safety of Longan Syrup in Healthy Volunteers With Insomnia
NCT ID: NCT04300036
Last Updated: 2020-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2020-03-01
2021-02-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
NCT06512363
Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers
NCT06496282
Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia
NCT00756002
Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
NCT00414102
Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia
NCT00656994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
longan syrup
Take 15 ml of longan syrup once a day for 3 months
longan syrup
Subjects will take 15 ml of longan syrup once a day for 3 months
Placebo syrup
Take 15 ml of placebo syrup once a day for 3 months
Placebo syrup
Subjects will take 15 ml of placebo syrup once a day for 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
longan syrup
Subjects will take 15 ml of longan syrup once a day for 3 months
Placebo syrup
Subjects will take 15 ml of placebo syrup once a day for 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Insomnia severity index (ISI) more than 7
* Thai- The Pittsburgh Sleep Quality Index (PSQI)) more than 5
* STOP - BANG less than 5
* No diabetes mellitus and thyroid dysfunction
* Fasting plasma glucose less than 126mg/dl
* Can communication (reading and writing)
* Be willing to be subjects in this study
Exclusion Criteria
* Take benzodiazepine, melatonin, valerian, and St Johns Wort in 1 month before this study starting
* Take medicines, herbs, or food supplements including thiazide diuretics, beta-blockers ,and estrogen that have an effect on blood sugar level in 1 month before this study starting
* Cannot control comorbidity diseases
* Irregular working hours
* Pregnancy or breast feeding
* Participated in other studies
35 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pornanong Aramwit, Pharm.D., Ph.D
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pornanong Aramwit, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Chulalongkorn University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
829/62
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.